Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Obesity is in epidemic proportions in many parts of the world, contributing to increasing rates of non-alcoholic fatty liver disease (NAFLD). NAFLD represents a range of conditions from the initial stage of fatty liver to non-alcoholic steatohepatitis (NASH), which can progress to severe fibrosis, t...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Antioxidants
المؤلفون الرئيسيون:	Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2024-04-01
الموضوعات:	ellagic acid urolithins non-alcoholic fatty liver disease non-alcoholic steatohepatitis dietarily interventions
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-3921/13/4/485

مواد مشابهة

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
حسب: Singh Deepak, وآخرون
منشور في: (2010-07-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
حسب: Ye. A. Fedos’ina, وآخرون
منشور في: (2010-06-01)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
حسب: Bo Zhu, وآخرون
منشور في: (2021-09-01)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
حسب: Yu Junjie, وآخرون
منشور في: (2023-01-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
حسب: Daryl Ramai, وآخرون
منشور في: (2021-02-01)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
حسب: Kyoungbun Lee, وآخرون
منشور في: (2020-05-01)

The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
حسب: Chunye Zhang, وآخرون
منشور في: (2022-04-01)

Progress on cholesterol metabolism and non-alcoholic steatohepatitis
حسب: LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
منشور في: (2022-07-01)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
حسب: Lauszus JS, وآخرون
منشور في: (2021-11-01)

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
حسب: T. Antofiichuk, وآخرون
منشور في: (2023-05-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
حسب: D. V. Garbuzenko
منشور في: (2022-01-01)

Combination of autoimmune hepatitis to non-alcoholic steatohepatitis (Clinical case)
حسب: A. A. Driga, وآخرون
منشور في: (2010-11-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
حسب: Xia Ziqiang, وآخرون
منشور في: (2023-01-01)

Transcriptional and Epigenetic Alterations in the Progression of Non-Alcoholic Fatty Liver Disease and Biomarkers Helping to Diagnose Non-Alcoholic Steatohepatitis
حسب: Yalan Zhu, وآخرون
منشور في: (2023-03-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
حسب: Gregory Habig, وآخرون
منشور في: (2021-04-01)

Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
حسب: Akihide Kamiya, وآخرون
منشور في: (2022-11-01)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
حسب: Zhen Yang, وآخرون
منشور في: (2023-03-01)

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics
حسب: Fei Xia, وآخرون
منشور في: (2024-08-01)

Nicotinic alpha‐7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non‐alcoholic steatohepatitis
حسب: Kumi Kimura, وآخرون
منشور في: (2019-05-01)

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
حسب: János Fehér, وآخرون
منشور في: (2005-04-01)

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
حسب: Chunye Zhang, وآخرون
منشور في: (2023-10-01)

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
حسب: Masatoshi Kudo
منشور في: (2021-07-01)

Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
حسب: Yeong Yeh Lee, وآخرون
منشور في: (2023-01-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study
حسب: Paraskevas Gkolfakis, وآخرون
منشور في: (2023-03-01)

Changes in direct markers of liver fibrosis in patients with steatohepatitis non-alcoholic and alcoholic origin on the background of obesity and pathology of the biliary tract
حسب: A. Yu. Filippova
منشور في: (2017-04-01)

Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action
حسب: Vanessa D. de Mello, وآخرون
منشور في: (2017-04-01)

Are N-acetylcysteine and adalimumab effective for non-alcoholic steatohepatitis?
حسب: Mustafa Yalçın, وآخرون
منشور في: (2016-08-01)

Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
حسب: Merve Cebi, وآخرون
منشور في: (2024-08-01)

Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis
حسب: Ryota Murata, وآخرون
منشور في: (2024-02-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
حسب: Daryl Ramai, وآخرون
منشور في: (2021-12-01)

Therapeutic Potential of Ellagic Acid in Liver Diseases
حسب: Karolina Wojtunik-Kulesza, وآخرون
منشور في: (2025-06-01)

The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
حسب: Osama Hamid, وآخرون
منشور في: (2022-09-01)

Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
حسب: Weiwei He, وآخرون
منشور في: (2023-01-01)

Silymarin and management of liver function in non-alcoholic steatohepatitis: a case report
حسب: Ahmed Hashem
منشور في: (2023-06-01)

Quantitative longitudinal investigation of non-alcoholic steatohepatitis in mice by photoacoustic microscopy
حسب: Jianshuang Wei, وآخرون
منشور في: (2025-08-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
حسب: Janet Sánchez-Quevedo, وآخرون
منشور في: (2022-09-01)

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
حسب: Nana Makiuchi, وآخرون
منشور في: (2023-09-01)

Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis
حسب: Helena Castañé, وآخرون
منشور في: (2023-11-01)

Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
حسب: Abolghasem Hadinia, وآخرون
منشور في: (2019-12-01)

Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective
حسب: Jia-Lan Wang, وآخرون
منشور في: (2024-03-01)